186 related articles for article (PubMed ID: 35055133)
1. The Peptide A-3302-B Isolated from a Marine Bacterium
Sureram S; Arduino I; Ueoka R; Rittà M; Francese R; Srivibool R; Darshana D; Piel J; Ruchirawat S; Muratori L; Lembo D; Kittakoop P; Donalisio M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055133
[TBL] [Abstract][Full Text] [Related]
2. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
mBio; 2019 May; 10(3):. PubMed ID: 31088925
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.
Luganini A; Nicoletto SF; Pizzuto L; Pirri G; Giuliani A; Landolfo S; Gribaudo G
Antimicrob Agents Chemother; 2011 Jul; 55(7):3231-9. PubMed ID: 21576438
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
[TBL] [Abstract][Full Text] [Related]
5. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a thiourea derivative that targets viral transactivators of cytomegalovirus and herpes simplex virus type 1.
Kondo H; Koshizuka T; Majima R; Takahashi K; Ishioka K; Suzutani T; Inoue N
Antiviral Res; 2021 Dec; 196():105207. PubMed ID: 34774602
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
8. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
9. Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia.
Cardozo FT; Camelini CM; Mascarello A; Rossi MJ; Nunes RJ; Barardi CR; de Mendonça MM; Simões CM
Antiviral Res; 2011 Oct; 92(1):108-14. PubMed ID: 21787804
[TBL] [Abstract][Full Text] [Related]
10. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antiviral activities of four local Malaysian Phyllanthus species against herpes simplex viruses and possible antiviral target.
Tan WC; Jaganath IB; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(13):1817-29. PubMed ID: 24324358
[TBL] [Abstract][Full Text] [Related]
12. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
14. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
16. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
17. Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501.
Wang Z; Jia J; Wang L; Li F; Wang Y; Jiang Y; Song X; Qin S; Zheng K; Ye J; Ren Z; Wang Y; Qi S
Virol J; 2020 Mar; 17(1):41. PubMed ID: 32192525
[TBL] [Abstract][Full Text] [Related]
18. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
19. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
